MSB 3.21% $1.13 mesoblast limited

Ann: Mesoblast Completes Resubmission of BLA to FDA for SR-aGVHD, page-901

  1. 7,655 Posts.
    lightbulb Created with Sketch. 6933
    Page after page of verbal hand bagging....yawn.

    Meanwhile the regulatory back drop has improved for MSB even in the three weeks since its BLA resubmission if you've been following the news closely. Leave the down rampers to themselves guys. Your time better spent elsewhere.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.